This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): BT088, Fovepta, Subcutaneous Hepatect, Human Hepatitis B Immunoglobulin (HBIG)
Description: Zutectra is the subcutaneously administered variant of Hepatect (approved in the EU, intravenously administered). Zutectra is a ready-to-use hepatitis B immunoglobulin solution in a pre-filledsyringe, enabling patients toself-medicate.
Additional information available to subscribers only: